Iveric Bio, An Astellas Company

Iveric Bio, An Astellas Company company information, Employees & Contact Information

Explore related pages

Iveric Bio, An Astellas Company email format Iveric Bio, An Astellas Company management contacts

Related company profiles:

Iveric Bio is now part of Astellas. Follow Astellas Pharma as we continue advancing therapies in ophthalmology. The Iveric Bio page is no longer active or monitored.

Company Details

Employees
87
Address
8 Sylvan Way, Parsippany,new Jersey 07054,united States
Phone
609.945.6050
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
ivericbio.com
Keywords
gene therapy, retinal disease, ophthamology, geographic atrophy.
HQ
Parsippany, New Jersey
Competitors
Eyenovia, Inc., Apellis Pharmaceuticals, Tarsus Pharmaceuticals, Inc., Novartis, Astellas Pharma, Opthea, EyePoint, Ocular Therapeutix, Inc., AbbVie, 4D Molecular Therapeutics.
Looking for a particular Iveric Bio, An Astellas Company employee's phone or email?

Iveric Bio, An Astellas Company Questions

News

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Astellas Pharma buys Iveric Bio for $5.9 billion - Reuters

Astellas Pharma buys Iveric Bio for $5.9 billion Reuters

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy - PR Newswire

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy PR Newswire

Iveric Bio Appoints Pravin U. Dugel, MD, to its Board of Directors - citybiz

Iveric Bio Appoints Pravin U. Dugel, MD, to its Board of Directors citybiz

Prenatal phenotype analysis and mutation identification of a fetus with meckel gruber syndrome - Frontiers

Prenatal phenotype analysis and mutation identification of a fetus with meckel gruber syndrome Frontiers

UMass Chan licenses gene therapy technologies for retinal diseases to Iveric Bio - UMass Chan Medical School

UMass Chan licenses gene therapy technologies for retinal diseases to Iveric Bio UMass Chan Medical School

Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD - Medical Professionals Reference

Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD Medical Professionals Reference

Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy - Business Wire

Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy Business Wire

Astellas Enters into Definitive Agreement to Acquire Iveric Bio - PR Newswire

Astellas Enters into Definitive Agreement to Acquire Iveric Bio PR Newswire

Iveric Bio Appoints Tony Gibney EVP - citybiz

Iveric Bio Appoints Tony Gibney EVP citybiz

Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy - PR Newswire

Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy PR Newswire

Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium for Investors - Business Wire

Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium for Investors Business Wire

David Guyer to Step Down from Iveric Bio Board to Rejoin Venture Fund - citybiz

David Guyer to Step Down from Iveric Bio Board to Rejoin Venture Fund citybiz

European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy - PR Newswire

European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy PR Newswire

Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors - Business Wire

Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors Business Wire

IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial - PR Newswire

IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial PR Newswire

Iveric Bio Receives FDA Agreement Under Special Protocol Assessment (SPA) for GATHER2 Phase 3 Clinical Trial of Zimura® in Geographic Atrophy Secondary to Age-Related Macular Degeneration - Business Wire

Iveric Bio Receives FDA Agreement Under Special Protocol Assessment (SPA) for GATHER2 Phase 3 Clinical Trial of Zimura® in Geographic Atrophy Secondary to Age-Related Macular Degeneration Business Wire

IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock - Business Wire

IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock Business Wire

Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy - PR Newswire

Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy PR Newswire

Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio - Business Wire

Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio Business Wire

Astellas Completes Acquisition of Iveric Bio - PR Newswire

Astellas Completes Acquisition of Iveric Bio PR Newswire

IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years - PR Newswire

IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years PR Newswire

Opus Genetics acquires two gene therapy candidates from Iveric Bio - Healio

Opus Genetics acquires two gene therapy candidates from Iveric Bio Healio

Addressing Unmet Needs in Retinal Diseases: Highlights From ARVO 2023 - Ophthalmology Advisor

Addressing Unmet Needs in Retinal Diseases: Highlights From ARVO 2023 Ophthalmology Advisor

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FinancialContent

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | User | ricentral.com - FinancialContent

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | User | ricentral.com FinancialContent

AAO 2023: Iveric Bio announces positive Phase 3 results for avacincaptad pegol intravitreal solution for GA secondary to AMD - Ophthalmology Times

AAO 2023: Iveric Bio announces positive Phase 3 results for avacincaptad pegol intravitreal solution for GA secondary to AMD Ophthalmology Times

Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer - FinancialContent

Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer FinancialContent

Companies like Iveric Bio, An Astellas Company

Novartis logo - Similar company to Iveric Bio, An Astellas Company

Novartis

79.78K
Ocular Therapeutix, Inc. logo - Similar company to Iveric Bio, An Astellas Company

Ocular Therapeutix, ...

308
4D Molecular Therapeutics logo - Similar company to Iveric Bio, An Astellas Company

4D Molecular Therape...

224
Apellis Pharmaceuticals logo - Similar company to Iveric Bio, An Astellas Company

Apellis Pharmaceuticals

783
Tarsus Pharmaceuticals, Inc. logo - Similar company to Iveric Bio, An Astellas Company

Tarsus Pharmaceutica...

367
Eyenovia, Inc. logo - Similar company to Iveric Bio, An Astellas Company

Eyenovia, Inc.

22
EyePoint logo - Similar company to Iveric Bio, An Astellas Company

Eyepoint

213
AbbVie logo - Similar company to Iveric Bio, An Astellas Company

Abbvie

57.01K
Opthea logo - Similar company to Iveric Bio, An Astellas Company

Opthea

45
Astellas Pharma logo - Similar company to Iveric Bio, An Astellas Company

Astellas Pharma

11.73K

Top Iveric Bio, An Astellas Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant